Search

Leading Pharma LLC Controlled Substances Importer Application Notice

The DEA published notice that Leading Pharma LLC, located in Fairfield, New Jersey, applied on March 25, 2026 to be registered as an importer of Diphenoxylate (Drug Code 9170, Schedule II). The company plans to import the controlled substance as an active pharmaceutical ingredient for research and development toward manufacturing a finished dosage product for FDA approval. Registered bulk manufacturers and applicants may submit comments or objections on or before May 21, 2026.

Importer of Controlled Substances Application: Leading Pharma LLC

The DEA published notice that Leading Pharma LLC, 3 Oak Road, Fairfield, New Jersey 07004, applied on March 25, 2026 to be registered as an importer of Diphenoxylate (drug code 9170, Schedule II controlled substance). The company plans to import the listed controlled substance as an active pharmaceutical ingredient for research and development toward manufacturing a finished dosage product for Food and Drug Administration approval. Public comments on the application and requests for a hearing must be submitted on or before May 21, 2026.

VA Cooperative Studies Program Importer Controlled Substances

The DEA published notice that VA Cooperative Studies Program applied on April 9, 2026, to be registered as an importer of controlled substances for research purposes. The application covers Marihuana Extract (Drug Code 7350) and Tetrahydrocannabinols (Drug Code 7370), Schedule I controlled substances, which the company plans to import as finished dosage unit products for clinical trial studies only. The DEA is accepting electronic comments and written hearing requests on the application through May 21, 2026.

Blue Rabbit Veterinary LLC Controlled Substance Importer Application

The DEA published notice that Blue Rabbit Veterinary LLC applied to be registered as an importer of Schedule II controlled substances Etorphine HCL (9059) and Thiafentanil (9729) for sale to veterinarians. The application was filed February 23, 2026, with comments on the registration due May 4, 2026.

Controlled Substances Importer Application - Research Triangle Institute

DEA published notice that Research Triangle Institute (Durham, NC) applied to be registered as an importer of controlled substances for 30 Schedule I drug classes including synthetic cathinones, benzodiazepine analogs, and other psychoactive substances. The application was filed March 3, 2026. Interested parties may submit comments or request hearings on the application through May 1, 2026.

Controlled Substance Importer Registration Application - MDMA

The DEA published notice that Fisher Clinical Services, Inc. applied on March 11, 2026 to be registered as an importer of 3,4-Methylenedioxy-methamphetamine (MDMA, Schedule I, drug code 7405) for clinical trials only. The company is located in Allentown, Pennsylvania. Registered bulk manufacturers and applicants may submit comments or objections, or request a hearing, by May 1, 2026.

Indivior Manufacturing LLC - Controlled Substances Importer Registration Application

The DEA published notice that Indivior Manufacturing LLC applied on February 26, 2026, to be registered as an importer of Thebaine (drug code 9333, Schedule II controlled substance). The company plans to import limited quantities for research, clinical trials, analytical purposes, and manufacturing process development of dosage forms. The public comment period closes on May 1, 2026.

Importer of Controlled Substances Application: Research Triangle Institute

The DEA published notice that Research Triangle Institute applied to be registered as an importer of Schedule I controlled substances, including cathinone derivatives and synthetic stimulants. The application covers basic class(es) of controlled substances listed in the Federal Register. Interested parties may submit comments or objections, or request a hearing on the application.

Controlled Substance Importer Application: Fisher Clinical Services

The Drug Enforcement Administration published a notice that Fisher Clinical Services, Inc. applied to be registered as an importer of a Schedule I controlled substance (3,4-Methylenedioxymethamphetamine, Drug Code 7405). The company plans to use the substance for clinical trials only. Registered manufacturers and applicants may submit comments or objections on or before May 1, 2026.

Controlled Substance Importer Application - Fisher Clinical Services

The DEA published a notice that Fisher Clinical Services, Inc. has applied to be registered as an importer of controlled substances. The application covers 3,4-Methylenedioxy-methamphetamine (MDMA, Schedule I, Drug Code 7405) for clinical trials only. The public comment period closes May 1, 2026.

Sterling Wisconsin LLC, controlled substances importer application

The Drug Enforcement Administration published a notice that Sterling Wisconsin, LLC applied to be registered as an importer of controlled substances (Drug Code 7431 - 5-Methoxy-N,N-dimethyltryptamine, Schedule I). The company plans to import this substance as bulk Active Pharmaceutical Ingredient for internal research, clinical investigational studies, and analytical purposes. Comments on the application are due May 1, 2026.

DEA Notice: Pisgah Laboratories Inc Importer Application

The Drug Enforcement Administration (DEA) has issued a notice regarding an application from Pisgah Laboratories Inc. to be registered as an importer of controlled substances, specifically Phenylacetone, Ecgonine, Thebaine, and Tapentadol. The public comment period for this application closes on April 20, 2026.